Monarch Capital Management Inc. Has $4.56 Million Holdings in Zimmer Biomet Holdings, Inc. (ZBH)

Monarch Capital Management Inc. raised its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,948 shares of the medical equipment provider’s stock after purchasing an additional 635 shares during the quarter. Zimmer Biomet Holdings makes up about 1.7% of Monarch Capital Management Inc.’s portfolio, making the stock its 26th biggest holding. Monarch Capital Management Inc.’s holdings in Zimmer Biomet Holdings were worth $4,560,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of ZBH. Enterprise Financial Services Corp lifted its position in shares of Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 9 shares during the last quarter. Cleararc Capital Inc. lifted its position in shares of Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after buying an additional 25 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Zimmer Biomet Holdings by 3.9% in the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after buying an additional 33 shares during the last quarter. CWA Asset Management Group LLC lifted its position in shares of Zimmer Biomet Holdings by 1.8% in the second quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after buying an additional 34 shares during the last quarter. Finally, Advisory Services Network LLC lifted its position in shares of Zimmer Biomet Holdings by 1.0% in the second quarter. Advisory Services Network LLC now owns 3,690 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 37 shares during the last quarter. Hedge funds and other institutional investors own 85.22% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) traded up 0.39% during midday trading on Friday, hitting $122.35. 788,636 shares of the stock were exchanged. The firm’s 50-day moving average is $116.85 and its 200-day moving average is $120.36. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The stock has a market cap of $24.74 billion, a price-to-earnings ratio of 34.85 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The firm’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.02 EPS. Equities research analysts predict that Zimmer Biomet Holdings, Inc. will post $8.23 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be given a $0.24 dividend. The ex-dividend date is Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.78%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is 27.59%.

In other news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.07% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://transcriptdaily.com/2017/10/20/monarch-capital-management-inc-has-4-56-million-holdings-in-zimmer-biomet-holdings-inc-zbh.html.

Several analysts recently weighed in on ZBH shares. Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. BMO Capital Markets reissued a “buy” rating and set a $136.00 price target on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Wells Fargo & Co reissued a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Morgan Stanley lifted their price target on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $136.55.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply